 | • レポートコード：QAF27799 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のナルコレプシー治療薬市場について種類別（酸化防止剤、覚醒剤、その他）、用途別（昼間極度眠気、脱力発作、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ナルコレプシー治療薬市場の概要 ・世界の主要地域別ナルコレプシー治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のナルコレプシー治療薬市場規模2016-2021：種類別（酸化防止剤、覚醒剤、その他） ・世界のナルコレプシー治療薬市場予測2012-2027：種類別（酸化防止剤、覚醒剤、その他） ・世界のナルコレプシー治療薬市場規模2016-2021：用途別（昼間極度眠気、脱力発作、その他） ・世界のナルコレプシー治療薬市場予測2012-2027：用途別（昼間極度眠気、脱力発作、その他） ・ナルコレプシー治療薬のアメリカ市場規模と予測2016-2021 ・ナルコレプシー治療薬のヨーロッパ市場規模と予測2016-2021 ・ナルコレプシー治療薬の中国市場規模と予測2016-2021 ・ナルコレプシー治療薬の日本市場規模と予測2016-2021 ・ナルコレプシー治療薬の東南アジア市場規模と予測2016-2021 ・ナルコレプシー治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jazz Pharmaceuticals、Teva Pharmaceutical、Novartis、Mylan） ・ナルコレプシー治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナルコレプシー治療薬の市場動向・機会・課題 ・調査の結論 |
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Narcolepsy Drug Market
The global Narcolepsy Drug market was valued at US$ 2775.5 in 2020 and will reach US$ 5052.6 million by the end of 2027, growing at a CAGR of 10.5% during 2022-2027.
Global Narcolepsy Drug Scope and Market Size
The global Narcolepsy Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Antioxidants
Stimulants
Others
Segment by Application
Daytime Extreme Sleepiness
Cataplexia
Others
The Narcolepsy Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Narcolepsy Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
1 Narcolepsy Drug Market Overview
1.1 Narcolepsy Drug Product Scope
1.2 Narcolepsy Drug Segment by Type
1.2.1 Global Narcolepsy Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Antioxidants
1.2.3 Stimulants
1.2.4 Others
1.3 Narcolepsy Drug Segment by Application
1.3.1 Global Narcolepsy Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Daytime Extreme Sleepiness
1.3.3 Cataplexia
1.3.4 Others
1.4 Narcolepsy Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Narcolepsy Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Narcolepsy Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Narcolepsy Drug Price Trends (2016-2027)
2 Narcolepsy Drug Estimates and Forecasts by Region
2.1 Global Narcolepsy Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Narcolepsy Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Narcolepsy Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Narcolepsy Drug Revenue Market Share by Region (2016-2021)
2.3 Global Narcolepsy Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Narcolepsy Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Narcolepsy Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Narcolepsy Drug Estimates and Projections (2016-2027)
2.4.2 Europe Narcolepsy Drug Estimates and Projections (2016-2027)
2.4.3 China Narcolepsy Drug Estimates and Projections (2016-2027)
2.4.4 Japan Narcolepsy Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Narcolepsy Drug Estimates and Projections (2016-2027)
2.4.6 India Narcolepsy Drug Estimates and Projections (2016-2027)
3 Global Narcolepsy Drug Competition Landscape by Players
3.1 Global Top Narcolepsy Drug Players by Sales (2016-2021)
3.2 Global Top Narcolepsy Drug Players by Revenue (2016-2021)
3.3 Global Narcolepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcolepsy Drug as of 2020)
3.4 Global Narcolepsy Drug Average Price by Company (2016-2021)
3.5 Manufacturers Narcolepsy Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Narcolepsy Drug Market Size by Type
4.1 Global Narcolepsy Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Narcolepsy Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Narcolepsy Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Narcolepsy Drug Price by Type (2016-2021)
4.2 Global Narcolepsy Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Narcolepsy Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Narcolepsy Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Narcolepsy Drug Price Forecast by Type (2022-2027)
5 Global Narcolepsy Drug Market Size by Application
5.1 Global Narcolepsy Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Narcolepsy Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Narcolepsy Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Narcolepsy Drug Price by Application (2016-2021)
5.2 Global Narcolepsy Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Narcolepsy Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Narcolepsy Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Narcolepsy Drug Price Forecast by Application (2022-2027)
6 North America Narcolepsy Drug Market Facts & Figures
6.1 North America Narcolepsy Drug Sales by Company
6.1.1 North America Narcolepsy Drug Sales by Company (2016-2021)
6.1.2 North America Narcolepsy Drug Revenue by Company (2016-2021)
6.2 North America Narcolepsy Drug Sales Breakdown by Type
6.2.1 North America Narcolepsy Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Narcolepsy Drug Sales Breakdown by Type (2022-2027)
6.3 North America Narcolepsy Drug Sales Breakdown by Application
6.3.1 North America Narcolepsy Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Narcolepsy Drug Sales Breakdown by Application (2022-2027)
7 Europe Narcolepsy Drug Market Facts & Figures
7.1 Europe Narcolepsy Drug Sales by Company
7.1.1 Europe Narcolepsy Drug Sales by Company (2016-2021)
7.1.2 Europe Narcolepsy Drug Revenue by Company (2016-2021)
7.2 Europe Narcolepsy Drug Sales Breakdown by Type
7.2.1 Europe Narcolepsy Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Narcolepsy Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Narcolepsy Drug Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Narcolepsy Drug Market Facts & Figures
8.1 China Narcolepsy Drug Sales by Company
8.1.1 China Narcolepsy Drug Sales by Company (2016-2021)
8.1.2 China Narcolepsy Drug Revenue by Company (2016-2021)
8.2 China Narcolepsy Drug Sales Breakdown by Type
8.2.1 China Narcolepsy Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Narcolepsy Drug Sales Breakdown by Type (2022-2027)
8.3 China Narcolepsy Drug Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan Narcolepsy Drug Market Facts & Figures
9.1 Japan Narcolepsy Drug Sales by Company
9.1.1 Japan Narcolepsy Drug Sales by Company (2016-2021)
9.1.2 Japan Narcolepsy Drug Revenue by Company (2016-2021)
9.2 Japan Narcolepsy Drug Sales Breakdown by Type
9.2.1 Japan Narcolepsy Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Narcolepsy Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Narcolepsy Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Narcolepsy Drug Market Facts & Figures
10.1 Southeast Asia Narcolepsy Drug Sales by Company
10.1.1 Southeast Asia Narcolepsy Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Narcolepsy Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Narcolepsy Drug Sales Breakdown by Type
10.2.1 Southeast Asia Narcolepsy Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Narcolepsy Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Narcolepsy Drug Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Narcolepsy Drug Market Facts & Figures
11.1 India Narcolepsy Drug Sales by Company
11.1.1 India Narcolepsy Drug Sales by Company (2016-2021)
11.1.2 India Narcolepsy Drug Revenue by Company (2016-2021)
11.2 India Narcolepsy Drug Sales Breakdown by Type
11.2.1 India Narcolepsy Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Narcolepsy Drug Sales Breakdown by Type (2022-2027)
11.3 India Narcolepsy Drug Sales Breakdown by Application
11.3.1 India Narcolepsy Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Narcolepsy Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Narcolepsy Drug Business
12.1 Jazz Pharmaceuticals
12.1.1 Jazz Pharmaceuticals Corporation Information
12.1.2 Jazz Pharmaceuticals Business Overview
12.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jazz Pharmaceuticals Narcolepsy Drug Products Offered
12.1.5 Jazz Pharmaceuticals Recent Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical Corporation Information
12.2.2 Teva Pharmaceutical Business Overview
12.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Pharmaceutical Narcolepsy Drug Products Offered
12.2.5 Teva Pharmaceutical Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Narcolepsy Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Narcolepsy Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Narcolepsy Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Narcolepsy Drug Products Offered
12.4.5 Mylan Recent Development
…
13 Narcolepsy Drug Manufacturing Cost Analysis
13.1 Narcolepsy Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Narcolepsy Drug
13.4 Narcolepsy Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Narcolepsy Drug Distributors List
14.3 Narcolepsy Drug Customers
15 Market Dynamics
15.1 Narcolepsy Drug Market Trends
15.2 Narcolepsy Drug Drivers
15.3 Narcolepsy Drug Market Challenges
15.4 Narcolepsy Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Narcolepsy Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Narcolepsy Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Narcolepsy Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Narcolepsy Drug Sales (MT) by Region (2016-2021)
Table 5. Global Narcolepsy Drug Sales Market Share by Region (2016-2021)
Table 6. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Narcolepsy Drug Revenue Share by Region (2016-2021)
Table 8. Global Narcolepsy Drug Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Narcolepsy Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Narcolepsy Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Narcolepsy Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Narcolepsy Drug Sales (MT) of Key Companies (2016-2021)
Table 13. Global Narcolepsy Drug Sales Share by Company (2016-2021)
Table 14. Global Narcolepsy Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Narcolepsy Drug Revenue Share by Company (2016-2021)
Table 16. Global Narcolepsy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Drug as of 2020)
Table 17. Global Narcolepsy Drug Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Narcolepsy Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Narcolepsy Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Narcolepsy Drug Sales (MT) by Type (2016-2021)
Table 22. Global Narcolepsy Drug Sales Share by Type (2016-2021)
Table 23. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Narcolepsy Drug Price (USD/MT) by Type (2016-2021)
Table 25. Global Narcolepsy Drug Sales Share by Type (2022-2027)
Table 26. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Narcolepsy Drug Revenue Share by Type (2022-2027)
Table 28. Global Narcolepsy Drug Price (USD/MT) by Type (2022-2027)
Table 29. Global Narcolepsy Drug Sales (MT) by Application (2016-2021)
Table 30. Global Narcolepsy Drug Sales Share by Application (2016-2021)
Table 31. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Narcolepsy Drug Price (USD/MT) by Application (2016-2021)
Table 33. Global Narcolepsy Drug Sales (MT) by Application (2022-2027)
Table 34. Global Narcolepsy Drug Sales Share by Application (2022-2027)
Table 35. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Narcolepsy Drug Revenue Share by Application (2022-2027)
Table 37. Global Narcolepsy Drug Price (USD/MT) by Application (2022-2027)
Table 38. North America Narcolepsy Drug Sales (MT) by Company (2016-2021)
Table 39. North America Narcolepsy Drug Sales Market Share by Company (2016-2021)
Table 40. North America Narcolepsy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Narcolepsy Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Narcolepsy Drug Sales by Type (2016-2021) & (MT)
Table 43. North America Narcolepsy Drug Sales Market Share by Type (2016-2021)
Table 44. North America Narcolepsy Drug Sales by Type (2022-2027) & (MT)
Table 45. North America Narcolepsy Drug Sales Market Share by Type (2022-2027)
Table 46. North America Narcolepsy Drug Sales by Application (2016-2021) & (MT)
Table 47. North America Narcolepsy Drug Sales Market Share by Application (2016-2021)
Table 48. North America Narcolepsy Drug Sales by Application (2022-2027) & (MT)
Table 49. North America Narcolepsy Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Narcolepsy Drug Sales (MT) by Company (2016-2021)
Table 51. Europe Narcolepsy Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Narcolepsy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Narcolepsy Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Narcolepsy Drug Sales by Type (2016-2021) & (MT)
Table 55. Europe Narcolepsy Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Narcolepsy Drug Sales by Type (2022-2027) & (MT)
Table 57. Europe Narcolepsy Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Narcolepsy Drug Sales by Application (2016-2021) & (MT)
Table 59. Europe Narcolepsy Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Narcolepsy Drug Sales by Application (2022-2027) & (MT)
Table 61. Europe Narcolepsy Drug Sales Market Share by Application (2022-2027)
Table 62. China Narcolepsy Drug Sales (MT) by Company (2016-2021)
Table 63. China Narcolepsy Drug Sales Market Share by Company (2016-2021)
Table 64. China Narcolepsy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Narcolepsy Drug Revenue Market Share by Company (2016-2021)
Table 66. China Narcolepsy Drug Sales by Type (2016-2021) & (MT)
Table 67. China Narcolepsy Drug Sales Market Share by Type (2016-2021)
Table 68. China Narcolepsy Drug Sales by Type (2022-2027) & (MT)
Table 69. China Narcolepsy Drug Sales Market Share by Type (2022-2027)
Table 70. China Narcolepsy Drug Sales by Application (2016-2021) & (MT)
Table 71. China Narcolepsy Drug Sales Market Share by Application (2016-2021)
Table 72. China Narcolepsy Drug Sales by Application (2022-2027) & (MT)
Table 73. China Narcolepsy Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Narcolepsy Drug Sales (MT) by Company (2016-2021)
Table 75. Japan Narcolepsy Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Narcolepsy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Narcolepsy Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Narcolepsy Drug Sales by Type (2016-2021) & (MT)
Table 79. Japan Narcolepsy Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Narcolepsy Drug Sales by Type (2022-2027) & (MT)
Table 81. Japan Narcolepsy Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Narcolepsy Drug Sales by Application (2016-2021) & (MT)
Table 83. Japan Narcolepsy Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Narcolepsy Drug Sales by Application (2022-2027) & (MT)
Table 85. Japan Narcolepsy Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Narcolepsy Drug Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Narcolepsy Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Narcolepsy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Narcolepsy Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Narcolepsy Drug Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Narcolepsy Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Narcolepsy Drug Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Narcolepsy Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Narcolepsy Drug Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Narcolepsy Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Narcolepsy Drug Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Narcolepsy Drug Sales Market Share by Application (2022-2027)
Table 98. India Narcolepsy Drug Sales (MT) by Company (2016-2021)
Table 99. India Narcolepsy Drug Sales Market Share by Company (2016-2021)
Table 100. India Narcolepsy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Narcolepsy Drug Revenue Market Share by Company (2016-2021)
Table 102. India Narcolepsy Drug Sales by Type (2016-2021) & (MT)
Table 103. India Narcolepsy Drug Sales Market Share by Type (2016-2021)
Table 104. India Narcolepsy Drug Sales by Type (2022-2027) & (MT)
Table 105. India Narcolepsy Drug Sales Market Share by Type (2022-2027)
Table 106. India Narcolepsy Drug Sales by Application (2016-2021) & (MT)
Table 107. India Narcolepsy Drug Sales Market Share by Application (2016-2021)
Table 108. India Narcolepsy Drug Sales by Application (2022-2027) & (MT)
Table 109. India Narcolepsy Drug Sales Market Share by Application (2022-2027)
Table 110. Jazz Pharmaceuticals Corporation Information
Table 111. Jazz Pharmaceuticals Description and Business Overview
Table 112. Jazz Pharmaceuticals Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Jazz Pharmaceuticals Narcolepsy Drug Product
Table 114. Jazz Pharmaceuticals Recent Development
Table 115. Teva Pharmaceutical Corporation Information
Table 116. Teva Pharmaceutical Description and Business Overview
Table 117. Teva Pharmaceutical Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Teva Pharmaceutical Narcolepsy Drug Product
Table 119. Teva Pharmaceutical Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Novartis Narcolepsy Drug Product
Table 124. Novartis Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Mylan Narcolepsy Drug Product
Table 129. Mylan Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Narcolepsy Drug Distributors List
Table 133. Narcolepsy Drug Customers List
Table 134. Narcolepsy Drug Market Trends
Table 135. Narcolepsy Drug Market Drivers
Table 136. Narcolepsy Drug Market Challenges
Table 137. Narcolepsy Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Narcolepsy Drug Product Picture
Figure 2. Global Narcolepsy Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Narcolepsy Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Daytime Extreme Sleepiness Examples
Figure 7. Cataplexia Examples
Figure 8. Others Examples
Figure 9. Global Narcolepsy Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Narcolepsy Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Narcolepsy Drug Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Narcolepsy Drug Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Narcolepsy Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Narcolepsy Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Narcolepsy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Narcolepsy Drug Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Narcolepsy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Narcolepsy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Narcolepsy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Narcolepsy Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Narcolepsy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Narcolepsy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Narcolepsy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Narcolepsy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Narcolepsy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Narcolepsy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Narcolepsy Drug Players Market Share by Revenue in Narcolepsy Drug: 2016 & 2020
Figure 28. Narcolepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Narcolepsy Drug Revenue Share by Type (2016-2021)
Figure 30. Global Narcolepsy Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Narcolepsy Drug Revenue Share by Application (2016-2021)
Figure 32. Global Narcolepsy Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Narcolepsy Drug Sales Market Share by Type in 2020
Figure 34. North America Narcolepsy Drug Sales Market Share by Application in 2020
Figure 35. Europe Narcolepsy Drug Sales Market Share by Type in 2020
Figure 36. Europe Narcolepsy Drug Sales Market Share by Application in 2020
Figure 37. China Narcolepsy Drug Sales Market Share by Type in 2020
Figure 38. China Narcolepsy Drug Sales Market Share by Application in 2020
Figure 39. Japan Narcolepsy Drug Sales Market Share by Type in 2020
Figure 40. Japan Narcolepsy Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Narcolepsy Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Narcolepsy Drug Sales Market Share by Application in 2020
Figure 43. India Narcolepsy Drug Sales Market Share by Type in 2020
Figure 44. India Narcolepsy Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Narcolepsy Drug
Figure 47. Manufacturing Process Analysis of Narcolepsy Drug
Figure 48. Narcolepsy Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…- 世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
- 世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…
- 抗体薬物複合体（ADC）のグローバル市場2021 Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…